Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Left atrial appendage closure: A single center experience and comparison of two contemporary devices.

Figini F, Mazzone P, Regazzoli D, Porata G, Ruparelia N, Giannini F, Stella S, Ancona F, Agricola E, Sora N, Marzi A, Aurelio A, Trevisi N, Della Bella P, Colombo A, Montorfano M.

Catheter Cardiovasc Interv. 2017 Mar 1;89(4):763-772. doi: 10.1002/ccd.26678. Epub 2016 Aug 27.

PMID:
27567013
2.

Long term follow-up of "full metal jacket" of de novo coronary lesions with new generation Zotarolimus-eluting stents.

Durante A, Foglia Manzillo G, Burzotta F, Trani C, Aurigemma C, Summaria F, Patrizi R, Talarico GP, Latib A, Figini F, Romagnoli E, De Vita M, Fantoni C, My L, Larosa C, Manzoli A, Turturo M, Berni A, Corrado G.

Int J Cardiol. 2016 Oct 15;221:1008-12. doi: 10.1016/j.ijcard.2016.07.050. Epub 2016 Jul 5.

PMID:
27441483
3.

Impact of post-procedural hyperglycemia on acute kidney injury after transcatheter aortic valve implantation.

Giannini F, Latib A, Jabbour RJ, Ruparelia N, Aurelio A, Ancona MB, Figini F, Mangieri A, Regazzoli D, Tanaka A, Montalto C, Azzalini L, Monaco F, Agricola E, Chieffo A, Montorfano M, Alfieri O, Colombo A.

Int J Cardiol. 2016 Oct 15;221:892-7. doi: 10.1016/j.ijcard.2016.07.029. Epub 2016 Jul 10.

PMID:
27434367
4.

A Comparison Between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience.

Ruparelia N, Latib A, Kawamoto H, Buzzatti N, Giannini F, Figini F, Mangieri A, Regazzoli D, Stella S, Sticchi A, Tanaka A, Ancona M, Agricola E, Monaco F, Spagnolo P, Chieffo A, Montorfano M, Alfieri O, Colombo A.

J Invasive Cardiol. 2016 May;28(5):210-6.

5.

Clinical outcomes following "off-label" versus "established" indications of bioresorbable scaffolds for the treatment of coronary artery disease in a real-world population.

Miyazaki T, Ruparelia N, Kawamoto H, Figini F, Latib A, Colombo A.

EuroIntervention. 2016 Apr 20;11(13):1475-8. doi: 10.4244/EIJV11I13A286.

6.

The use of a scoring balloon for optimal lesion preparation prior to bioresorbable scaffold implantation: a comparison with conventional balloon predilatation.

Miyazaki T, Latib A, Ruparelia N, Kawamoto H, Sato K, Figini F, Colombo A.

EuroIntervention. 2016 Apr 8;11(14):e1580-8. doi: 10.4244/EIJV11I14A308.

7.

Initial findings using the V8 hourglass-shaped valvuloplasty balloon for postdilatation in treating paravalvular leaks associated with transcatheter self-expanding aortic valve prosthesis.

Latib A, Pedersen W, Maisano F, Lesser J, Ruparelia N, Figini F, Colombo A, Poulose A, Kolbeck J, Mooney M, Schwartz R, Youssef A, Ungs D, Goldenberg I, Sorajja P.

Catheter Cardiovasc Interv. 2016 Jun;87(7):1306-13. doi: 10.1002/ccd.26462. Epub 2016 Mar 6.

PMID:
26945697
8.

Long-Term Outcomes After Transcatheter Aortic Valve Implantation from a Single High-Volume Center (The Milan Experience).

Ruparelia N, Latib A, Buzzatti N, Giannini F, Figini F, Mangieri A, Regazzoli D, Stella S, Sticchi A, Kawamoto H, Tanaka A, Agricola E, Monaco F, Castiglioni A, Ancona M, Cioni M, Spagnolo P, Chieffo A, Montorfano M, Alfieri O, Colombo A.

Am J Cardiol. 2016 Mar 1;117(5):813-9. doi: 10.1016/j.amjcard.2015.12.014. Epub 2015 Dec 13.

PMID:
26742477
9.

Severe Neointimal Hyperplasia of Neoplastic Carina Following Bioresorbable Scaffold Implantation Using T-Stenting and Small Protrusion Technique: Insights From Optical Frequency Domain Imaging.

Kawamoto H, Ruparelia N, Figini F, Latib A, Colombo A.

JACC Cardiovasc Interv. 2015 Nov;8(13):e207-9. doi: 10.1016/j.jcin.2015.05.031. Epub 2015 Oct 14. No abstract available.

10.

Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis.

Kawamoto H, Ruparelia N, Latib A, Miyazaki T, Sato K, Mangieri A, Contri R, Stella S, Figini F, Chieffo A, Carlino M, Montorfano M, Colombo A.

JACC Cardiovasc Interv. 2015 Oct;8(12):1586-94. doi: 10.1016/j.jcin.2015.04.032. Epub 2015 Sep 17.

11.

Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure.

Tanaka A, Ruparelia N, Kawamoto H, Sticchi A, Figini F, Carlino M, Chieffo A, Montorfano M, Latib A, Colombo A.

Catheter Cardiovasc Interv. 2016 Apr;87(5):832-6. doi: 10.1002/ccd.26171. Epub 2015 Sep 2.

PMID:
26331577
12.

Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade.

Carlino M, Figini F, Ruparelia N, Uretsky BF, Godino C, Latib A, Bertoldi L, Brilakis E, Karmpaliotis D, Antoniucci D, Margonato A, Colombo A.

Catheter Cardiovasc Interv. 2016 Apr;87(5):884-92. doi: 10.1002/ccd.26103. Epub 2015 Aug 26.

PMID:
26308750
13.

Routine Screening of Coronary Artery Disease With Computed Tomographic Coronary Angiography in Place of Invasive Coronary Angiography in Patients Undergoing Transcatheter Aortic Valve Replacement.

Chieffo A, Giustino G, Spagnolo P, Panoulas VF, Montorfano M, Latib A, Figini F, Agricola E, Gerli C, Franco A, Giglio M, Cioni M, Alfieri O, Camici PG, Colombo A.

Circ Cardiovasc Interv. 2015 Jul;8(7):e002025. doi: 10.1161/CIRCINTERVENTIONS.114.002025.

14.

Transfemoral transcatheter aortic valve implantation in patients with small diseased peripheral vessels.

Ruparelia N, Buzzatti N, Romano V, Longoni M, Figini F, Montorfano M, Kawamoto H, Miyazaki T, Spagnolo P, Alfieri O, Colombo A, Latib A.

Cardiovasc Revasc Med. 2015 Sep;16(6):326-30. doi: 10.1016/j.carrev.2015.05.013. Epub 2015 Jun 3.

PMID:
26104848
15.

Successful implantation of a second-generation aortic valve in severe aortic regurgitation secondary to a traumatic cusp lesion.

Mangieri A, Latib A, Aurelio A, Figini F, Agricola E, Rosa I, Stella S, Spagnolo P, Castiglioni A, Colombo A.

Cardiovasc Revasc Med. 2015 Oct-Nov;16(7):429-31. doi: 10.1016/j.carrev.2015.04.007. Epub 2015 May 6.

PMID:
26070636
16.

Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: Overall outcomes and comparison between provisional and planned double stenting strategy.

Kawamoto H, Latib A, Ruparelia N, Miyazaki T, Sticchi A, Naganuma T, Sato K, Figini F, Chieffo A, Carlino M, Montorfano M, Colombo A.

Catheter Cardiovasc Interv. 2015 Oct;86(4):644-52. doi: 10.1002/ccd.26045. Epub 2015 May 27.

PMID:
26013748
17.

Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent.

Kawamoto H, Panoulas VF, Sato K, Miyazaki T, Naganuma T, Sticchi A, Figini F, Latib A, Chieffo A, Carlino M, Montorfano M, Colombo A.

JACC Cardiovasc Interv. 2015 Jun;8(7):900-9. doi: 10.1016/j.jcin.2015.02.011. Epub 2015 May 20.

18.

Influence of baseline ejection fraction on the prognostic value of paravalvular leak after transcatheter aortic valve implantation.

Miyazaki S, Agricola E, Panoulas VF, Slavich M, Giustino G, Miyazaki T, Figini F, Latib A, Chieffo A, Montorfano M, Margonato A, Maisano F, Alfieri O, Colombo A.

Int J Cardiol. 2015;190:277-81. doi: 10.1016/j.ijcard.2015.04.190. Epub 2015 Apr 24.

PMID:
25932806
19.

Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds.

Panoulas VF, Miyazaki T, Sato K, Naganuma T, Sticchi A, Kawamoto H, Figini F, Chieffo A, Carlino M, Montorfano M, Latib A, Colombo A.

EuroIntervention. 2016 Mar;11(12):1355-62. doi: 10.4244/EIJY15M03_11.

20.

Impact and natural history of postprocedural aortic regurgitation on early and midterm mortality following transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis.

Ielasi A, Latib A, Sacco FM, Costopoulos C, Figini F, Grimaldi A, Naim C, Maisano F, Chieffo A, Montorfano M, Alfieri O, Colombo A.

J Cardiovasc Med (Hagerstown). 2015 Apr;16(4):286-95. doi: 10.2459/JCM.0000000000000249.

PMID:
25643194

Supplemental Content

Loading ...
Support Center